Flurazepam is a long-acting benzodiazepine derivative primarily utilized as a sedative-hypnotic agent for the treatment of insomnia, while also possessing antianxiety and anticonvulsant properties. In… Read more



![Chemical structure of 7-Chloro-1-(2-(ethylamino)ethyl)-5-(2-fluorophenyl)-1,3,4,5-tetrahydro-2H-benzo[e][1,4]diazepin-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F100234-77-3-7-Chloro-1-2-ethylaminoethyl-5-2-fluorophenyl-1345-tetrahydro-2H-benzoe14diazepin-2-one.png&w=3840&q=75)









Flurazepam is a long-acting benzodiazepine derivative primarily utilized as a sedative-hypnotic agent for the treatment of insomnia, while also possessing antianxiety and anticonvulsant properties. In pharmaceutical research and manufacturing, high-quality reference standards are essential for the rigorous quality control and characterization of this drug. This category includes the parent active pharmaceutical ingredient alongside a comprehensive range of related compounds, such as pharmacopeial and non-pharmacopeial impurities, N-oxides, and desalkylated degradation products formed through hydrolysis or oxidation. These materials are critical for impurity profiling and the validation of analytical methods to ensure regulatory compliance. Additionally, stable isotope labelled compounds are provided to support precise quantitative analysis and pharmacokinetic studies, enabling laboratories to accurately monitor drug metabolites and degradation pathways throughout the product lifecycle.